MedPath
HSA Approval

ACTAL TABLET 216 mg

SIN03572P

ACTAL TABLET 216 mg

ACTAL TABLET 216 mg

June 30, 1989

A. MENARINI SINGAPORE PTE. LTD.

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantA. MENARINI SINGAPORE PTE. LTD.
Licence HolderA. MENARINI SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

**DOSAGE** Adult (tablet must be sucked and chewed) Peptic ulcer: Suck and chew 2 to 4 tablets. Gastric hyperacidity: Suck and chew 1 to 2 tablets, one-half to one hour after each meal. Heartburn of pregnancy: Suck and chew 1 to 2 tablets before breakfast and one half-hour after each meal.

ORAL

Medical Information

**INDICATIONS** For the relief of stomach discomfort such as indigestion, heartburn due to gastric hyperacidity, peptic ulcer and heartburn of pregnancy.

A02AB01

aluminium hydroxide

Manufacturer Information

A. MENARINI SINGAPORE PTE. LTD.

PHARMANIAGA MANUFACTURING BERHAD

PT. MENARINI INDRIA LABORATORIES

Active Ingredients

DRIED ALUMINIUM HYDROXIDE 360 mg eqv to ALUMINIUM HYDROXIDE

216 mg

Aluminum hydroxide

Documents

Patient Information Leaflets

Actal Tablet PIL.pdf

Approved: April 29, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACTAL TABLET 216 mg - HSA Approval | MedPath